METHOD FOR DISTINGUISHING PULMONARY ARTERY AND PULMONARY VEIN, AND METHOD FOR QUANTIFYING BLOOD VESSELS USING SAME
    82.
    发明申请
    METHOD FOR DISTINGUISHING PULMONARY ARTERY AND PULMONARY VEIN, AND METHOD FOR QUANTIFYING BLOOD VESSELS USING SAME 有权
    肺动脉血管和肺动脉分离术的方法及使用其定量血管的方法

    公开(公告)号:US20160117814A1

    公开(公告)日:2016-04-28

    申请号:US14881817

    申请日:2015-10-13

    Abstract: A method for distinguishing between pulmonary arteries and pulmonary veins and a method for quantifying blood vessels are disclosed. The method for distinguishing between pulmonary arteries and pulmonary veins includes: forming a set of pulmonary vessels for points corresponding to pulmonary vessels, wherein each of the points of the set of pulmonary vessels has weight information; forming a tree from the points of the set of pulmonary vessels by using the weight information; and distinguishing between the pulmonary arteries and the pulmonary veins by separating the tree into a plurality of regions. The method for quantifying blood vessels includes: extracting blood vessels as a three-dimensional set of voxels based on medical images of an organ; finding the voxels of blood vessels included in a region of interest of the organ; and quantifying length information of the blood vessels by using the found voxels.

    Abstract translation: 公开了一种用于区分肺动脉和肺静脉的方法以及用于定量血管的方法。 用于区分肺动脉和肺静脉的方法包括:形成一组对应于肺血管的点的肺血管,其中该组肺动脉血管的每个点具有体重信息; 通过使用权重信息从该组肺血管的点形成树; 并通过将树分离成多个区域来区分肺动脉和肺静脉。 量化血管的方法包括:基于器官的医学图像将血管提取为三维体素组; 找到包含在器官感兴趣区域的血管的体素; 以及通过使用发现的体素来量化血管的长度信息。

    MARKER COMPOSITION COMPRISING S1P PROTEIN FOR PREDICTION OF RISK IN OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS
    83.
    发明申请
    MARKER COMPOSITION COMPRISING S1P PROTEIN FOR PREDICTION OF RISK IN OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS 审中-公开
    包含S1P蛋白质的标记物组合物,用于预测OSTEOPOROTIC FRACTURE和OSTEOPOSOSIS的风险

    公开(公告)号:US20130331282A1

    公开(公告)日:2013-12-12

    申请号:US13865688

    申请日:2013-04-18

    Abstract: Disclosed herein is a marker composition that includes sphingosine 1-phosphate (S1P) protein and that may be used to predict the risk of fracture or osteoporosis; a kit that includes an antibody that specifically binds to the S1P protein and that can be used to predict the risk of fracture or osteoporosis; and a method that can be used to obtain information that allows prediction of the risk of fracture or osteoporosis and includes measurements of S1P protein concentrations by measuring the binding of a S1P-specific antibody to S1P protein. The S1P protein disclosed herein is highly expressed in individuals with fracture, regardless of their bone mineral density. Accordingly, it may be useful as a biomarker of the risk of fracture or osteoporosis.

    Abstract translation: 本文公开了包含鞘氨醇1-磷酸(S1P)蛋白质并可用于预测骨折或骨质疏松症风险的标记物组合物; 包括特异性结合S1P蛋白并可用于预测骨折或骨质疏松症风险的抗体的试剂盒; 以及可用于获得允许预测骨折或骨质疏松症风险的信息的方法,并且包括通过测量S1P特异性抗体与S1P蛋白的结合来测量S1P蛋白浓度。 本文公开的S1P蛋白质在具有骨折的个体中高度表达,而不管其骨矿物质密度如何。 因此,作为骨折或骨质疏松症风险的生物标志物可能是有用的。

    CORNEAL ENDOTHELIAL TISSUE TRANSPLANTATION SYSTEM

    公开(公告)号:US20250041046A1

    公开(公告)日:2025-02-06

    申请号:US18715840

    申请日:2022-12-02

    Abstract: The present disclosure relates to a corneal endothelial tissue transplantation system for easily and precisely moving corneal endothelial tissue inserted into an anterior chamber of an eyeball. To this end, the corneal endothelial tissue transplantation system according to an embodiment of the present disclosure includes a tissue carrier to which cultured corneal endothelial tissue is attached and which is inserted into an anterior chamber of an eyeball, a magnetic field generation module including at least one magnetic field generator which generates a magnetic field for moving the tissue carrier, and a support plate which supports the magnetic field generator, and a user input module which receives an input signal for controlling the magnetic field generator from a user.

Patent Agency Ranking